Enlivex Secures $21 Million Debt Financing for Rain Prediction Market Tokens

By WSN Editorial TeamTech ReporterMarch 25, 20263 min readUpdated less than an hour ago

Enlivex exercises an option to acquire Rain tokens and announces a share buyback program amid its strategy to bolster its treasury with cryptocurrencies.

Israeli immunotherapy company Enlivex has raised $21 million via a debt financing agreement from The Lind Partners to acquire 3 billion Rain tokens for its treasury.

The company exercised an option to buy the tokens at a 62% discount for $10 million on Sunday and extended its option to purchase an additional 272.1 billion Rain tokens at the same discounted price until December 2027.

Enlivex's Strategy and Token Acquisition

Enlivex executive chair Shai Novik stated that the financing allows the company to continue its operating plan while expanding its holdings in Rain tokens, part of a broader treasury strategy involving cryptocurrencies.

Enlivex, which develops cell therapy solutions for conditions like knee osteoarthritis, aims to strengthen its balance sheet and attract more investors through these crypto purchases.

In addition to the token acquisition, Enlivex approved a $20 million share buyback program to enhance shareholder value.

The Rain token operates on the Ethereum Layer-2 network Arbitrum and is tied to a decentralized prediction market platform that features a 2.5% fee to buy back and burn tokens, potentially improving its supply-demand dynamics.

According to CoinGecko data, the Rain token rose 7% to $0.009 following the announcement but traded flat over the last 24 hours with a 0.3% gain. Enlivex shares closed down 0.9% at $1.10 but gained 4.5% in after-hours trading to $1.15.

Rain ranks among the top 10 prediction market platforms by total value locked and fees, with prediction markets seeing overall trading volumes increase more than 1,200% in the past year, though dominated by competitors like Kalshi and Polymarket.